Andres Jerez
Overview
Explore the profile of Andres Jerez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
1893
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sanchez-Maldonado J, Cabrera-Serrano A, Chattopadhyay S, Campa D, Garrido M, Macauda A, et al.
Int J Mol Sci
. 2023 Apr;
24(7).
PMID: 37047000
Multiple myeloma (MM) is an incurable disease characterized by the presence of malignant plasma cells in the bone marrow that secrete specific monoclonal immunoglobulins into the blood. Obesity has been...
12.
Calvete O, Mestre J, Jerez A, Sole F
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900275
There is a great deal of controversy in the hematologic community regarding the classification of secondary myelodysplastic neoplasms (MDSs). Current classifications are based on the presence of genetic predisposition and...
13.
Wang Y, Yao C, Lin C, Gurashi K, Amaral F, Bossenbroek H, et al.
Br J Haematol
. 2023 Feb;
201(2):302-307.
PMID: 36746431
Leukaemic stem cell (LSC) gene expression has recently been linked to prognosis in patients with acute myeloid leukaemia (17-gene LSC score, LSC-17) and myelodysplastic syndromes. Although chronic myelomonocytic leukaemia (CMML)...
14.
Carrillo-Tornel S, Chen-Liang T, Zurdo M, Puiggros A, Gomez-Llonin A, Garcia-Malo M, et al.
Br J Haematol
. 2022 Dec;
201(3):470-479.
PMID: 36573331
Studies prior to next-generation sequencing (NGS) showed that the frequent indolent course of chronic lymphocytic leukaemia (CLL) is related to most cells remaining quiescent in the G -G cell cycle...
15.
Rodenas-Quinonero I, Chen-Liang T, Martin-Santos T, Salar A, Fernandez-Gonzalez M, Celades C, et al.
Cancer Med
. 2022 Nov;
12(6):6536-6546.
PMID: 36373169
Backgound: In the workup of follicular lymphoma (FL), bone marrow biopsy (BMB) assessment is a key component of FLIPI and FLIPI2, the most widely used outcome scores. During the previous...
16.
Garcia-Martin P, Diez A, Maldonado J, Serrano A, Ter Horst R, Benavente Y, et al.
Blood Cancer J
. 2022 May;
12(5):79.
PMID: 35581176
No abstract available.
17.
Morales D, Jerez A, Arguello H
Appl Opt
. 2022 Mar;
61(9):F25-F33.
PMID: 35333223
Phase retrieval (PR) arises from the lack of phase information in the measures recorded by optical sensors. Phase masks that modulate the optical field and reduce ambiguities in the PR...
18.
Bravo-Perez C, Carrillo-Tornel S, Garcia-Torralba E, Jerez A
Cancers (Basel)
. 2022 Mar;
14(5).
PMID: 35267648
Large granular lymphocyte leukemia (LGLL) is a chronic disease of either mature phenotype cytotoxic CD3+ T lymphocytes or CD3- NK cells. LGLL diagnosis is hampered by the fact that reactive...
19.
Bravo-Perez C, Sola M, Teruel-Montoya R, Garcia-Malo M, Ortuno F, Vicente V, et al.
Cancers (Basel)
. 2021 Sep;
13(17).
PMID: 34503142
The game-changing outcome effect, due to the generalized use of novel agents in MM, has cre-ated a paradigm shift. Achieving frequent deep responses has placed MM among those neoplasms where...
20.
Martin I, Villamon E, Abellan R, Calasanz M, Irigoyen A, Sanz G, et al.
Br J Haematol
. 2021 Jul;
194(4):708-717.
PMID: 34296432
In myelodysplastic syndromes (MDS), the 20q deletion [del(20q)] may cause deletion of the ASXL1 gene. We studied 153 patients with MDS and del(20q) to assess the incidence, prognostic value and...